In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Covidien's DVT compression system gets FDA green light

This article was originally published in Clinica

Executive Summary

The US FDA has granted 510(k) clearance for Covidien's Kendall SCD sequential compression comfort sleeve and Kendall SCD 700 series controller. The devices are designed to reduce the incidence of deep vein thrombosis (DVT) and pulmonary embolism, while avoiding the risk of bleeding found with anticoagulant drugs. The device is more comfortable than older systems, Mansfield, Massachusetts-based Covidien says, and addresses problems such as sweating, heat, itchiness and skin irritation. A 148-patient trial found that 84% preferred the new product over Covidien's older Kendall SCD Express sleeve.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts